Dennis Mazingi is a medical doctor and general surgeon with a special interest in paediatric injury prevention, global surgery, and surgically correctable NCDs. He has worked in clinical medicine and surgery in southern Africa for almost a decade and is currently pursuing a DPhil in the University of Oxford’s Nuffield Department of Surgical Sciences in the global surgery group.

His work focuses on trauma surveillance and quality improvement in paediatric trauma care in Zimbabwe. He is ably supervised by Professor Kokila Lakhoo and Professor Ashok Handa at the Nuffield Department of Surgical Sciences and Professor Godfrey Muguti at the University of Zimbabwe.

Prior to joining The George Institute Dennis obtained his undergraduate medical degree at the University of Malawi, College of Medicine and an MMed (Master’s in Medicine) in General Surgery at the University of Zimbabwe, College of Health Sciences. He holds a first-class degree in International Health and Tropical Medicine (IHTM) from the University of Oxford and is a fellow of the College of Surgeons of South Africa as well as a Beit Trust Scholar.

He has worked in various research collaboratives in the field of global surgery, paediatric surgery, and general surgery. Dennis’s other interests lie in clinical surgery, surgical education, disruptive health technologies, frugal innovations, health systems and implementation research.

Dennis wants to see a healthier, more prosperous, more equitable world through surgical care and research. His mission is to help accelerate progress towards SDG target 3.6: to halve the number of deaths and injuries from road traffic accidents by 2030 in Zimbabwe and globally; and to scale up quality surgical and anaesthesia care to the 5 billion people who need it through 2030 and beyond.

Martin is Professorial Fellow at the George Institute, Head of the South Western Sydney Campus for the Faculty of Medicine & Health at UNSW, and a clinical nephrologist at Liverpool Hospital.

He has worked extensively within the ANZ Society of Nephrology in renal guidelines, clinical policy and research.

Martin’s research interests include large scale clinical trials to explore ways to improve the outcomes of patients with kidney disease (esp in the setting of acute kidney injury), measurement of health systems and applying research evidence into clinical practice.

Ms Sarah Coggan is a Senior Project Manager at the George Institute for Global Health (TGI) as well as for George Clinical, TGI’s commercial partner company. She has more than 15 years of experience working in clinical trials both in the academic and commercial settings.

Sarah has a science background in Pharmacology/ Communication and a Masters of Public Health. She began employment at the George Institute in July 2012 and has remained within the Renal Program, including 2 years based remotely in the United States. Her expertise lies in the implementation of pragmatic randomised clinical trials, data linkage, building collaborative relationships with commercial and academic Sponsors, and implementing corporate knowledge within future renal research activities.

Maoyi Tian is a honorary senior fellow working in The George Institute China. He received his Bachelor of Electronic Engineering from University of York, UK and his MSc of Biomedical Engineering from University of Oxford, UK.

He graduated with his PhD in Biomedical Engineering from University of New South Wales in Sydney, Australia. He is currently a MPhil candidate in Epidemiology in The University of Sydney. His main research focus is using mobile health and health technology for chronic disease management and prevention in the primary care setting, particularly the integration of the mobile health or health technology into the existing health care system.

Alta Schutte is a SHARP Professor and Theme Lead for Cardiac, Vascular and Metabolic Medicine at UNSW Sydney; and Professorial Fellow at The George Institute Australia. She holds honorary appointments at the North-West University and University of the Witwatersrand in South Africa. She is the Past President of the International Society of Hypertension, Company Secretary of the Australian Cardiovascular Alliance, and Co-Chair of the Australian National Hypertension Taskforce.

Alta is a leading researcher with extensive experience in clinical trials and population-based studies in the field of blood pressure, hypertension and cardiovascular health. She has been the Chief Investigator of several multidisciplinary studies, published >450 papers in the field, and supervised over 85 postgraduate students. She is Chief Investigator of several Australian-funded trials and is a NHMRC Investigator Grant Leadership Fellow.

She is involved in numerous international consortia, such as the Global Burden of Disease study, the NCD Risk Factor Collaboration, May Measurement Month global blood pressure screening campaign, World Health Organization working groups and the Lancet Commission of Hypertension. She is the senior author of the 2020 International Society of Hypertension Global Hypertension Guidelines. She is Associate Editor of the journal, Hypertension, and has received numerous international awards for her work, most recently the 2022 American Heart Association’s Harriet Dustan Award, and 2023 Peter Sleight Excellence Award in Hypertension Clinical Research from the World Hypertension League.

Anthony Sunjaya is a medical doctor from Indonesia and Honorary Fellow at the Respiratory and Health Systems Division, The George Institute for Global Health, UNSW Sydney, Australia. He is also an Honorary Research Fellow at the School of Public Health, Imperial College London and a Visiting Researcher at the Royal Brompton and Harefield Hospitals.

His research focuses on cardiorespiratory diseases, complex chronic diseases, primary care, and digital health especially the development, validation and translation of decision support systems, AI, and virtual care. He has a special interest in supporting universal health coverage, improving care, especially in low-resource settings and primary care through the use of innovative evidence-based solutions.

He is Chief Investigator of the Breathlessness Rapid Evaluation and THErapy (BREATHE) trial funded by the Australian Government Medical Research Future Fund to optimise the assessment and management of chronic breathlessness in primary care through implementation of a clinical decision support system for breathlessness across 40 GP practices in Australia building upon work during his PhD which was supported by the UNSW Scientia PhD program.

He is currently Chair, Primary Care SIG, Thoracic Society of Australia and New Zealand (TSANZ); Chair, Membership Committee, Society of Medical Decision Making (SMDM); Vice-Chair of the Digital Transformation Leadership working group in the International Society for Telemedicine and e-Health (ISfTeH), and Editorial Advisory Board member of the Annals of Family Medicine. He is also an active social entrepreneur and co-founder of BantingMed, a diabetes digital health startup.

He was previously President of Postgraduate Council UNSW and ASEAN Society UNSW, a delegate to the 2023 Group of 7 Youth Summit in Japan and has contributed to reports for the World Health Organization and Asthma Australia.

After completion of her Masters, Sudha started her career in clinical research at Clinigene International Ltd, sister concerns of Biocon. She has worked in clinical research industry for the past five and a half years and was part of George Clinical for nearly four years.

Sudha has had experience in working on academic trials and seeks to pursue higher education and training in public health research, especially in the areas of non-communicable diseases including mental health and injuries.

She is currently involved in a study where mobile-based technology is being used to provide basic mental health care to scheduled tribe villages in rural Andhra Pradesh. 

Maree is responsible for designing, leading, and delivering a distinctive and vibrant postgraduate, postdoctoral and future leader research experience at The George. Maree and her team provide management and oversight of ‘higher degree by research’ candidates, their supervisors, visiting fellows and work with the training team to co-ordinate postgraduate research training.

Maree also leads a program of research focusing on developing simple, cost-effective strategies to prevent depression and significantly improve the outcome for people with chronic disease.

Maree works one day per week as a Professor of Epidemiology in the Faculty of Health and Wellbeing at The University of Central Lancashire in the United Kingdom.

Anna is working as an Associate Project Manager working on the STARS (stroke) and STEPCARE (cardiac arrest) studies. Since joining The George Institute in 2019 she has worked as a Senior Clinical Research Associate on various studies, both in Critical Care as well as other medical fields.  Prior to her employment at The George Institute, Anna was a Clinical Trials and Research Coordinator for the Intensive Care Units at Western Health, Victoria.  Anna has also worked as a Clinical Research Associate for Orion Clinical Services (CRO) and as a Research Coordinator for the Gastroenterology Department at Box Hill Hospital.  She also has a Bachelor of Biomedical Science with Honors from the University of South Australia, a Postgraduate Diploma in Forensic Science from La Trobe University and a Postgraduate Certificate in Business Administration from Swinburne University.

Dr Kotwal is a clinical nephrologist at the Prince of Wales Hospital in Sydney; Program Head of the Renal and Metabolic Division at The George Institute for Global Health and a Conjoint Senior Lecturer at UNSW. Her research interests include novel and pragmatic clinical trials and she is passionate about increasing clinical trial access for patients with kidney disease and personalised medicine. Dr Kotwal is the Academic Project Director for the GKPTN and the principal investigator for the Glomerular Disease Registry and Biobank in Sydney. She has expertise in translating research into clinical practice and in-depth knowledge of statistical techniques, epidemiology and clinical trial design.